Introduction

At The Retina Clinic London, we are dedicated to advancing retinal care through cutting-edge research and clinical innovation. We actively collaborate with the pharmaceutical industry to bring the latest treatments to patients, ensuring that individuals have greater choice in their ophthalmic care.

All clinical trials conducted at our clinic have full ethics committee approvals, ensuring patient safety, ethical integrity, and scientific validity. In many of these studies, Professor Paulo Stanga serves as the Chief Investigator at a national level, overseeing the trial’s implementation across multiple sites and playing a key role in the ethics approval process.

Our clinical trials provide patients with early access to pioneering therapies, often years before they become widely available. Led by Professor Stanga and his team of world-renowned retinal specialists, we focus on developing new diagnostic techniques, advanced treatments, and surgical innovations to improve vision outcomes.

Current Clinical Trials

We are currently recruiting for clinical trials in the following conditions:

  • Geographic Atrophy (GA). Dry AMD
  • Wet Age-Related Macular Degeneration (Wet AMD)
  • Vitreous Floaters & Opacities (VFO)
  • Diabetic Retinopathy & Diabetic Maculopathy
  • Gene Therapy for Inherited Retinal Diseases (including X-Linked Retinitis Pigmentosa, Usher Syndrome Type 1B, and Stargardt Disease)

If you are interested in participating in a trial, our team will guide you through the process to determine if a study is suitable for you.

Who Can Benefit from Clinical Trials?

Patients who take part in research studies may:

  • Gain access to cutting-edge treatments before they become widely available.
  • Receive close monitoring and specialist care throughout the study.
  • Help advance medical knowledge and improve future treatment options for others.

Many of our trials focus on conditions where existing treatments are limited, such as early-stage Dry AMD, advanced Diabetic Maculopathy, and inherited retinal diseases.

Eligibility is assessed on a case-by-case basis, and participation is entirely voluntary.

How Does Participation Work?

We aim to make it as easy as possible for patients to participate in clinical trials. The process typically follows these steps:

  1. Speak with Our Team. If you are interested in a trial, we will discuss your condition and medical history to see if participation might be suitable for you.
  2. Pre-Screening (Free of Charge). Before a full screening, we may conduct a preliminary assessment to check whether you are likely to meet eligibility criteria. This avoids unnecessary time spent on further assessments if a trial is not suitable.
  3. Full Screening & Enrolment. If pre-screening suggests suitability, you will be invited for a full screening, including advanced imaging and diagnostic tests. If eligible, you will be formally enrolled in the study and begin treatment.

In most cases, if a condition affects both eyes, clinical trials will cover treatment for the fellow eye (e.g., Wet AMD trials often include both eyes if needed).

Supporting You on Your Research Journey

At The Retina Clinic London, we understand that taking part in a clinical trial is a meaningful decision, and we’re here to ensure that your experience is as smooth and supported as possible.

All study-related costs are fully covered, including treatments, tests, and follow-up appointments.

Depending on the specific study, allowances may be available to reimburse travel and accommodation expenses, including those for a companion if permitted. Please note that the availability of these allowances—and the maximum amounts that can be reimbursed—are determined by each individual study.

Where included, overnight stays can also be arranged for patients travelling from further afield.

Our goal is to remove unnecessary barriers to participation, so that those who wish to contribute to research—and potentially benefit from early access to innovative treatments—can do so comfortably and with peace of mind.

Why Choose The Retina Clinic London for Clinical Trials?

At The Retina Clinic London, research is a key part of our mission to deliver world-class retinal care. Patients choose us because of:

Global Expertise. Led by Professor Paulo Stanga and a team of leading retinal specialists, we are at the forefront of ophthalmic research.

State-of-the-Art Imaging & Diagnostics. We use the most advanced imaging technologies, including high-resolution OCT and AI-driven analysis, to ensure precise assessments.

Access to Revolutionary Treatments. Clinical trial participants receive cutting-edge therapies before they become widely available.

Personalised Care & Long-Term Monitoring. Patients benefit from regular follow-ups and individualised treatment plans.

Commitment to Innovation. We are actively involved in developing the future of retinal care, ensuring the latest advancements are available to our patients.

Find Out More

If you are interested n learning more about our clinical trials, or would like to see if you qualify for a study, contact us today.

Call us on: +44 (0)20 4548 5310
Email us at: info@theretinacliniclondon.com